Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogens.

Menopause (New York, N.Y.)

Volumn 20, Issue 11, 2013, Pages 1126-1132

  Gallagher, John Christopher ^a   Shi, Harry ^b   Mirkin, Sebastian ^b   Chines, Arkadi A ^b  

^a CREIGHTON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BONE DENSITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HOT FLASHES; HUMAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

BONE DENSITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, CONJUGATED (USP); FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; QUALITY OF LIFE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84900133083     PISSN: None     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31828ac8cc     Document Type: Article

References (0)